Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 1, 2008, Pages 33-40

  Liu, Yang ^a   Yang, Youyun ^a   Qi, Jing ^a   Peng, Hui ^a   Zhang, Jian Ting ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CHIMERIC PROTEIN; CYSTEINE DERIVATIVE; OLIGOMER;

ARTICLE; DISULFIDE BOND; DRUG TRANSPORT; GENE MAPPING; GENE MUTATION; MUTAGENESIS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CYSTEINE; DISULFIDES; HUMANS; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; PROTEIN BINDING; SPODOPTERA;

EID: 45749107106     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.138115     Document Type: Article

References (24)

1. Allen JD and Schinkel AH (2002) Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 1:427-434.
2. Bakos E, Evers R, Calenda G, Tusnady GE, Szakacs G, Varadi A, and Sarkadi B (2000) Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J Cell Sci 113:4451-4461.
3. Bakos E, Klein I, Welker E, Szabo K, Muller M, Sarkadi B, and Varadi A (1997) Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region. Biochem J 323 (Pt 3):777-783.
4. Bhatia A, Schafer HJ, and Hrycyna CA (2005) Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers. Biochemistry 44:10893-10904.
5. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, and Welsh MJ (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761-764.
6. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, and Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95:15665-15670.
7. Han B and Zhang JT (2004) Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2. Curr Med Chem Anticancer Agents 4:31-42.
8. Henriksen U, Fog JU, Litman T, and Gether U (2005) Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2. J Biol Chem 280:36926-36934.
9. Kage K, Fujita T, and Sugimoto Y (2005) Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2. Cancer Sci 96:866-872.
10. Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, and Sugimoto Y (2002) Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 97:626-630.
11. Lee SH and Altenberg GA (2003) Transport of leukotriene C4 by a cysteine-less multidrug resistance protein 1 (MRP1). Biochem J 370:357-360.
12. Litman T, Jensen U, Hansen A, Covitz KM, Zhan Z, Fetsch P, Abati A, Hansen PR, Horn T, Skovsgaard T, et al. (2002) Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim Biophys Acta 1565:6-16.
13. Loo TW and Clarke DM (1995) Membrane topology of a cysteine-less mutant of human P-glycoprotein. J Biol Chem 270:843-848.
14. McDevitt CA, Collins RF, Conway M, Modok S, Storm J, Kerr ID, Ford RC, and Callaghan R (2006) Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. Structure 14:1623-1632.
15. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, et al. (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 59:8-13.
16. Ozvegy C, Varadi A, and Sarkadi B (2002) Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. J Biol Chem 277:47980-47990.
17. Urbatsch IL, Gimi K, Wilke-Mounts S, Lerner-Marmarosh N, Rousseau M-E, Gros P, and Senior AE (2001) Cysteines 431 and 1074 are responsible for inhibitory disulfide cross-linking between the two nucleotide-binding sites in human Pglycoprotein. J Biol Chem 276:26980-26987.
18. Wakabayashi K, Nakagawa H, Adachi T, Kii I, Kobatake E, Kudo A, and Ishikawa T (2006) Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system. J Exp Ther Oncol 5:205-222.
19. Wakabayashi K, Nakagawa H, Tamura A, Koshiba S, Hoshijima K, Komada M, and Ishikawa T (2007) Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein. J Biol Chem 282:27841-27846.
20. Xu J, Liu Y, Yang Y, Bates S, and Zhang JT (2004) Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem 279:19781-19789.
21. Xu J, Peng H, Chen Q, Liu Y, Dong Z, and Zhang JT (2007a) Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity. Cancer Res 67:4373-4381.
22. Xu J, Peng H, and Zhang JT (2007b) Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy. Curr Med Chem 14:689-701.
23. Yang Y, Chen Q, and Zhang JT (2002) Structural and functional consequences of mutating cysteine residues in the amino terminus of human multidrug resistanceassociated protein 1. J Biol Chem 277:44268-44277.
24. Zhang JT (2007) Biochemistry and pharmacology of the human multidrug resistance gene product, ABCG2. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:531-541.